4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-003173
VP Finance & Accounting sold 6,607 shares at $14.00 ($92,498)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomson Peter G. VP Finance & Accounting | 2021-01-21 | Sale | −6,607 | $14.00 | $92,498 | 15,212 | D: show line 1 in the form |
| Open-market sales · 6,607 sh · avg $14.00 · $92,498 | |||||||
Loading xslF345X03/doc4.xml…